Cart
sales@molnova.com
Fluorocytosine
CAS No. 2022-85-7
Fluorocytosine( Ancobon | Ancotil | 5-FC | NSC 103805 | Ro 2-9915 )
Catalog No. M13149 CAS No. 2022-85-7
Flucytosine is a Nucleoside Analog Antifungal. The chemical classification of flucytosine is Nucleoside Analog.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 43 | In Stock |
|
Biological Information
-
Product NameFluorocytosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionFlucytosine is a Nucleoside Analog Antifungal. The chemical classification of flucytosine is Nucleoside Analog.
-
DescriptionFlucytosine is a Nucleoside Analog Antifungal. The chemical classification of flucytosine is Nucleoside Analog.
-
In Vitro——
-
In Vivo——
-
SynonymsAncobon | Ancotil | 5-FC | NSC 103805 | Ro 2-9915
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA synthesis
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number2022-85-7
-
Formula Weight129.09
-
Molecular FormulaC4H4FN3O
-
Purity>98% (HPLC)
-
SolubilityWater: 5 mg/mL (38.73 mM); DMSO: 8 mg/mL (61.97 mM)
-
SMILESO=C1N=CC(F)=C(N)N1
-
Chemical Name6-amino-5-fluoro-1H-pyrimidin-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Mechlorethamine hydr...
Mechlorethamine hydrochloride is a vesicant and necrotizing irritant destructive to mucous membranes.
-
BVDV-IN-1
BVDV-IN-1 is a non-nucleoside inhibitor (NNI) of bovine viral diarrhea virus (BVDV), with an EC50 of 1.8 μM.?It directly binds to a hydrophobic pocket of the BVDV RdRp.
-
HALOFUGINONE LACTATE
HALOFUGINONE LACTATE is a halogenated derivative of febrifugine, a natural quinazolinone-containing compound found in the Chinese herb D. febrifuga.Halofuginone inhibits prolyl-tRNA synthetase in an ATP-dependent manner with a Ki of 18.3 nM.?Halofuginone is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibition of TGF-β activityhalofuginone (HF), a widely studied derivative of febrifugine, inhibits the development of T(H)17-driven autoimmunity in a mouse model of multiple sclerosis by activating the amino acid response (AAR) pathway.?HF binds glutamyl-prolyl-tRNA synthetase (EPRS), inhibiting prolyl-tRNA synthetase activity;?this inhibition is reversed by the addition of exogenous proline or EPRS.
